The well-established biological functions of FGF21 as a key regulator of energy balance, glucose homeostasis, fat metabolism and insulin sensitivity provide clues as to the SLC6A19 loss-associated protection against obesity and metabolic syndrome. The gene discussed is INS; the disease is obesity disorder.